Therapeutic effects of statins on osteoarthritis: A review

Shirin Saberianpour, Samaneh Abolbashari, Mohamad H.S. Modaghegh, Maryam S. Karimian, Ali H. Eid, Thozhukat Sathyapalan, Amirhossein Sahebkar

Research output: Contribution to journalReview articlepeer-review

4 Citations (Scopus)


Osteoarthritis (OA) is a progressive joint disease. The etiology of OA is considered to be multifactorial. Currently, there is no definitive treatment for OA, and the existing treatments are not very effective. Hypercholesterolemia is considered a novel risk factor for the development of OA. Statins act as a competitive inhibitor of the β-hydroxy β-methylglutaryl-CoA (HMG-CoA) reductase and are widely used to manage hypercholesterolemia. Inhibition of HMG-CoA reductase results in reduced synthesis of a metabolite named mevalonate, thereby reducing cholesterol biosynthesis in subsequent steps. By this mechanism, statins such as atorvastatin and simvastatin could potentially have a preventive impact on joint cartilage experiencing osteoarthritic deterioration by reducing serum cholesterol levels. Atorvastatin can protect cartilage degradation following interleukin-1β-stimulation. Atorvastatin stimulates the STAT1-caspase-3 signaling pathway that was shown to be responsible for its anti-inflammatory effects on the knee joint. Simvastatin had chondroprotective effects on OA in vitro by reducing matrix metalloproteinases expression patterns. In this study, we tried to review the therapeutic effects of statins on OA.
Original languageEnglish
Pages (from-to)1285-1297
Number of pages13
JournalJournal of Cellular Biochemistry
Issue number8
Publication statusPublished - Aug 2022


Dive into the research topics of 'Therapeutic effects of statins on osteoarthritis: A review'. Together they form a unique fingerprint.

Cite this